Bugworks
Drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR).
Launch date
Employees
Market cap
-
Enterprise valuation
€65—98m (Dealroom.co estimates Feb 2022.)
Bengaluru Karnataka (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Early VC | |
$9.0m | Series A | ||
* | $7.5m | Series B | |
* | $18.0m | Series B | |
* | N/A | $6.8m | Growth Equity VC |
Total Funding | €39.0m |
Related Content
Recent News about Bugworks
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.